Rethinking Advanced Thyroid Cancer: Neoadjuvant Therapy and the Future of Surgery

Knowledge Is Power: Helping Patients Navigate Healthcare Access and Affordability

Many patients believe that once a prescription is written, receiving treatment is a straightforward process. In reality, prior authorizations, insurance requirements, specialty pharmacy restrictions, and affordability challenges can create significant barriers to accessing care. In this episode of MedInsights Unleashed, Patrick R. Coyle MBA, joins John Collins to discuss the complexities of healthcare access and affordability. Together, they explore how patients can better understand the prescription journey, navigate insurance denials, utilize available support programs, and become stronger advocates for their own care.

RASolute 302: The First Major Breakthrough in Pancreatic Cancer in Decades

The RASolute 302 trial represents a breakthrough in pancreatic cancer treatment, successfully doubling patient survival compared with standard care. In this episode of MedInsights Unleashed, Prof. Philip Philip, Professor of Medical Oncology, Wayne State University School of Medicine and Henry Ford Cancer Institute, discusses how targeting KRAS mutations may change the treatment landscape for pancreatic cancer, reviews the final ASCO analysis, and explains what these findings mean for patients, caregivers, and clinicians. While not a cure, the study offers new hope by extending survival, improving quality of life, and opening the door to a new era of targeted therapy research.

Rethinking Advanced Thyroid Cancer: Neoadjuvant Therapy and the Future of Surgery

In this episode of MedInsights Unleashed, John Collins speaks with Professor Gregory Randolph MD, FACS, FACE, Bertucci Chair in Thyroid Surgical Oncology at Harvard Medical School, about the evolving role of neoadjuvant therapy in advanced thyroid cancer. The discussion explores the challenges of locally invasive thyroid cancer and how neoadjuvant lenvatinib prior to surgery may help improve surgical outcomes, reduce morbidity, and preserve critical structures such as the recurrent laryngeal nerve. The conversation also highlights findings from a multicenter Phase 2 clinical trial, including promising results related to nerve preservation, vocal cord recovery, and the future of multidisciplinary thyroid cancer care.

CPR, CPR-102, AEDs, and DNRs: What Everyone Should Know in an Emergency

In this episode of MedInsights Unleashed, John Collins speaks with Devin Hinchcliffe about one of the most important life-saving interventions in medicine and emergency care ��� CPR. The discussion explores CPR fundamentals, CPR-102 updates, AED use, DNR considerations, and why rapid intervention by both healthcare professionals and members of the community can significantly improve outcomes during cardiac emergencies. Drawing from his experience in Emergency Medical Services, law enforcement, and EMS education, Devin provides practical insights into emergency response, first responder training, and the importance of public awareness and preparedness. This episode offers valuable information for healthcare professionals, caregivers, first responders, and members of the public who want a better understanding of CPR and emergency response.

Beyond Aortic Valve Replacement: Understanding Flow Dynamics and the Role of DurAVR THV

In this episode of MedInsights Unleashed, Wayne Paterson, Vice Chairman and CEO of Anteris Technologies, joins us to discuss one of the fastest evolving areas in structural heart disease ��� whether the future of valve replacement lies not only in replacing diseased valves, but also in restoring more natural heart flow. The discussion explores aortic stenosis, the evolution of TAVR, and the emerging science and MRI data surrounding DurAVR THV, including the potential importance of flow dynamics, laminar flow, durability, and long-term valve performance. We also discuss patient selection, future valve innovation, and how next-generation technologies may move beyond simply treating obstruction toward restoring more natural cardiovascular physiology.